[Hyperlipoproteinemias: experience of out-patient treatment of 112 patients (author's transl)].
作者信息
Arteaga A, Maiz A, Lathrop R
出版信息
Rev Med Chil. 1981 Oct;109(10):945-51.
PMID:7344018
Abstract
摘要
相似文献
1
[Hyperlipoproteinemias: experience of out-patient treatment of 112 patients (author's transl)].[高脂蛋白血症：112例门诊治疗经验（作者译）]
Rev Med Chil. 1981 Oct;109(10):945-51.
2
[Lipoproteins and hyperlipoproteinemias].[脂蛋白与高脂蛋白血症]
Fortschr Med. 1980 Mar 6;98(9):313-6.
3
The primary hyperlipoproteinemias.原发性高脂血症。
J Ky Med Assoc. 1974 Dec;72(12):658-62.
4
5
[Clofibrate banned - what now? (author's transl)].安妥明被禁用 - 现在怎么办？（作者译）
MMW Munch Med Wochenschr. 1979 Apr 13;121(15):529-33.
6
Hyperlipidemia: reducing the chances of cardiovascular disease.
Geriatrics. 1984 Jul;39(7):99-100, 103-4,108-9 passim.
7
[Low dose clofibrate in the treatment of hypertriglyceridemia in hemodialysis patients (author's transl)].
Med Clin (Barc). 1980 Nov 10;75(8):334-7.
8
The efficacy of lipid lowering drugs alone and in combination.
Postgrad Med J. 1975;51(8):63-5.
9
[Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
Med Klin. 1976 Mar 19;71(12):513-7.
10
Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.血脂降低对心血管发病率和死亡率的影响。临床证据与治疗指南。
Arq Bras Cardiol. 1988 Jul;51(1):43-8.
Zotero 插件